Ken Griffin Neurosense Therapeutics LTD Wt Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Neurosense Therapeutics LTD Wt stock. As of the latest transaction made, Citadel Advisors LLC holds 29,464 shares of NRSNW stock, worth $5,303. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,464
Previous 48,138
38.79%
Holding current value
$5,303
Previous $20,000
70.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NRSNW
# of Institutions
6Shares Held
281KCall Options Held
0Put Options Held
0-
Empery Asset Management, LP New York, NY160KShares$28,8000.28% of portfolio
-
Clear Street LLC59.3KShares$10,6680.0% of portfolio
-
Warberg Asset Management LLC Winnetka, IL32KShares$5,7610.03% of portfolio
-
Ubs Group Ag605Shares$1080.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio